CAGR Value :
The global pneumatic compression devices for lymphedema market was valued at USD 331 million in 2025 and is projected to reach USD 673 million by 2032, at a CAGR of 11.0% during the forecast period.
Report Studies :
Pneumatic compression therapy is a non-invasive treatment that utilizes compressed air to apply pressure to the limbs. It is a standard of care for managing lymphedema, a condition characterized by localized fluid retention and tissue swelling caused by a compromised lymphatic system. The devices consist of an inflatable garment (sleeve or boot) connected to a pump that generates controlled, rhythmic compression. This action helps to reduce swelling, improve lymphatic drainage, and enhance overall circulation. The market growth is primarily driven by the rising prevalence of cancer, as treatments like surgery and radiation can damage the lymphatic system and lead to secondary lymphedema. Furthermore, an increasing geriatric population, which is more susceptible to chronic venous insufficiency and other conditions that can lead to lymphedema, is contributing to market expansion. Technological advancements leading to more portable and user-friendly devices for home care settings are also supporting market growth.
By Types :
Lower Extremity
Upper Extremity
By
Applications :
Home Use
Hospital & Clinic
• Others
Key Industry Players
• Tactile Medical
• DS MAREF
• ArjoHuntleigh
• Mego Afek
• Bio Compression Systems, Inc.
• Bösl Medizintechnik
• Airos Medical
• BTL Corporate
• Devon Medical Products
• Lympha Press
• medi GmbH & Co. KG
• Wright Therapy Products (an Arjo company)
• Currie Medical Specialties
• NormaTec (a Hyperice company)
• ThermoTek